MAPK Signaling
Research Areas
Products Related to MAPK Signaling(660)
- GC38755CKI-7CAS: 120615-25-0Purity: >99.00%
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases.
- GC39074Tenuifoliside ACAS: 139726-35-5Purity: >99.50%
Tenuifoliside A is isolated from Polygala tenuifolia, has anti-apoptotic and antidepressant-like effects.
- GC39095Isoliquiritin apiosideCAS: 120926-46-7Purity: >99.50%
Isoliquiritin apioside significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells.
- GC393252,5-DihydroxyacetophenoneCAS: 490-78-8Purity: >99.50%
2,5-Dihydroxyacetophenone, isolated from Rehmanniae Radix Preparata, inhibits the production of inflammatory mediators in activated macrophages by blocking the ERK1/2 and NF-κB signaling pathways.
- GC39815Semapimod tetrahydrochlorideCAS: 164301-51-3Purity: >98.00%
Semapimod tetrahydrochloride (CNI-1493), an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6.
- GC40213Regorafenib-13C-d3CAS: 2126178-55-8Purity: >99.00%
Regorafenib-13C-d3 is intended for use as an internal standard for the quantification of regorafenib by GC- or LC-MS.
- GC40231Milrinone-d3CAS: 2749393-50-6Purity: >99.00%
Milrinone-d3 is intended for use as an internal standard for the quantification of milrinone by GC- or LC-MS.
- GC40484Ferulic Acid methyl esterCAS: 2309-07-1Purity: >99.00%
Ferulic acid is a hydroxycinnamic acid that is abundant in plants and originally derived from giant fennel (F.
- GC40924InflachromeneCAS: 908568-01-4Purity: >98.00%
Inflachromene is an inhibitor of HMGB1 and HMGB expression. Inflachromene can inhibit the release of HMGB1 and the NF-κB signaling pathway, exerting anti-inflammatory and neuroprotective effects. Inflachromene is mainly used to treat epilepsy.
- GC414235-trans Prostaglandin E2CAS: 36150-00-2Purity: >98.00%
5-trans PGE2 occurs naturally in some gorgonian corals and is a common impurity in commercial lots of PGE1.
- GC41513Nε-(1-Carboxymethyl)-L-lysineCAS: 5746-04-3Purity: >95.00%
Nε-(1-Carboxymethyl)-L-lysine is a unique post-translational modification (PTM) of proteins that is generated by the non-enzymatic glycation of lysine residues.
- GC41573Theaflavin 3,3'-digallateCAS: 30462-35-2Purity: >98.00%
Theaflavin 3,3'-digallate (TF-3; ZP10) is a potent inhibitor of Zika virus (ZIKV) protease with an IC 50 value of 2.3μM.
- GC41635Phosphodiesterase 4 InhibitorCAS: 346440-86-6Purity: >98.00%
Phosphodiesterase 4 (PDE4) inhibitor is an inhibitor of PDE4 with an IC50 value of 0.10 μM for the human recombinant enzyme.
- GC41656(±)2-(14,15-Epoxyeicosatrienoyl) GlycerolCAS: 848667-56-1Purity: >95.00%
2-Arachidonoyl glycerol (2-AG) is an endogenous central cannabinoid (CB1) receptor agonist that is present at relatively high levels in the central nervous system.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC38738 | Azosemide | 27589-33-9 | >97.00% | |
Azosemide, a sulfonamide loop diuretic, is a potent NKCC1 inhibitor with IC50s of 0.246??M and 0.197??M for hNKCC1A and NKCC1B, respectively. | ||||
| GC38755 | CKI-7 | 120615-25-0 | >99.00% | |
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases. | ||||
| GC38791 | GSK-25 | 874119-56-9 | >99.50% | |
GSK-25 is a potent, selective and orally bioavailable ROCK1 inhibitor (IC50=7 nM). | ||||
| GC38804 | JWG-071 | 2250323-50-1 | >99.50% | |
JWG-071 is the first reported kinase-selective chemical probe for ERK5. JWG-071 improves ERK5 activity and BRD4 selectivity. JWG-071 will be a much-needed chemical probe for deconvoluting ERK5 and BRD4 pharmacology. | ||||
| GC38917 | Gossypetin | 489-35-0 | >99.00% | |
A flavonoid with diverse biological activities | ||||
| GC39074 | Tenuifoliside A | 139726-35-5 | >99.50% | |
Tenuifoliside A is isolated from Polygala tenuifolia, has anti-apoptotic and antidepressant-like effects. | ||||
| GC39095 | Isoliquiritin apioside | 120926-46-7 | >99.50% | |
Isoliquiritin apioside significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells. | ||||
| GC39325 | 2,5-Dihydroxyacetophenone | 490-78-8 | >99.50% | |
2,5-Dihydroxyacetophenone, isolated from Rehmanniae Radix Preparata, inhibits the production of inflammatory mediators in activated macrophages by blocking the ERK1/2 and NF-κB signaling pathways. | ||||
| GC39485 | CK2/ERK8-IN-1 | 1085822-09-8 | >99.00% | |
A dual inhibitor of CK2 and ERK8 | ||||
| GC39574 | SR-318 | 2413286-32-3 | >98.50% | |
A dual inhibitor of p38α and p38β MAPKs | ||||
| GC39715 | M2698 | 1379545-95-5 | >99.50% | |
M2698 (MSC2363318A) is an orally active, ATP competitive, selective p70S6K and Akt dual-inhibitor with IC50s of 1 nM for p70S6K, Akt1 and Akt3. M2698 can cross the blood-brain barrier and has anti-cancer activity. | ||||
| GC39815 | Semapimod tetrahydrochloride | 164301-51-3 | >98.00% | |
Semapimod tetrahydrochloride (CNI-1493), an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6. | ||||
| GC40054 | CCT241161 | 1163719-91-2 | >98.00% | |
CCT241161 is a multi-kinase inhibitor that inhibits B-RAF, B-RAFV600E, C-RAF, Src, and LCK (IC50s = 252, 15, 6, 15, and 3 nM, respectively). | ||||
| GC40213 | Regorafenib-13C-d3 | 2126178-55-8 | >99.00% | |
Regorafenib-13C-d3 is intended for use as an internal standard for the quantification of regorafenib by GC- or LC-MS. | ||||
| GC40231 | Milrinone-d3 | 2749393-50-6 | >99.00% | |
Milrinone-d3 is intended for use as an internal standard for the quantification of milrinone by GC- or LC-MS. | ||||
| GC40352 | Cafestol | 469-83-0 | >98.00% | |
Cafestol, one of the major components of coffee, is a coffee-specific diterpene form and an inhibitor of ERK2. | ||||
| GC40484 | Ferulic Acid methyl ester | 2309-07-1 | >99.00% | |
Ferulic acid is a hydroxycinnamic acid that is abundant in plants and originally derived from giant fennel (F. | ||||
| GC40650 | CAY10706 | 1881270-27-4 | >95.00% | |
CAY10706 is a ligustrazine-curcumin hybrid that promotes intracellular reactive oxygen species accumulation preferentially in lung cancer cells. | ||||
| GC40924 | Inflachromene | 908568-01-4 | >98.00% | |
Inflachromene is an inhibitor of HMGB1 and HMGB expression. Inflachromene can inhibit the release of HMGB1 and the NF-κB signaling pathway, exerting anti-inflammatory and neuroprotective effects. Inflachromene is mainly used to treat epilepsy. | ||||
| GC41423 | 5-trans Prostaglandin E2 | 36150-00-2 | >98.00% | |
5-trans PGE2 occurs naturally in some gorgonian corals and is a common impurity in commercial lots of PGE1. | ||||
| GC41513 | Nε-(1-Carboxymethyl)-L-lysine | 5746-04-3 | >95.00% | |
Nε-(1-Carboxymethyl)-L-lysine is a unique post-translational modification (PTM) of proteins that is generated by the non-enzymatic glycation of lysine residues. | ||||
| GC41573 | Theaflavin 3,3'-digallate | 30462-35-2 | >98.00% | |
Theaflavin 3,3'-digallate (TF-3; ZP10) is a potent inhibitor of Zika virus (ZIKV) protease with an IC 50 value of 2.3μM. | ||||
| GC41635 | Phosphodiesterase 4 Inhibitor | 346440-86-6 | >98.00% | |
Phosphodiesterase 4 (PDE4) inhibitor is an inhibitor of PDE4 with an IC50 value of 0.10 μM for the human recombinant enzyme. | ||||
| GC41656 | (±)2-(14,15-Epoxyeicosatrienoyl) Glycerol | 848667-56-1 | >95.00% | |
2-Arachidonoyl glycerol (2-AG) is an endogenous central cannabinoid (CB1) receptor agonist that is present at relatively high levels in the central nervous system. | ||||
